UA
48
9
GT
60
13
NTAP
54
2
C
54
4
CHD
45
3
BIIB
38
2
RF
54
3
RL
72
3
MU
39
5
NDAQ
56
3
JPM
59
3
KR
44
4
CL
50
2
EXPD
40
3
PGR
58
6
FOXA
63
3
IVZ
52
6
AA
47
4
PFG
36
3
EFX
40
4
UA
48
9
GT
60
13
NTAP
54
2
C
54
4
CHD
45
3
BIIB
38
2
RF
54
3
RL
72
3
MU
39
5
NDAQ
56
3
JPM
59
3
KR
44
4
CL
50
2
EXPD
40
3
PGR
58
6
FOXA
63
3
IVZ
52
6
AA
47
4
PFG
36
3
EFX
40
4
Financhill
Back

Kazia Therapeutics 10K Form

Buy
75

KZIA
Kazia Therapeutics

Last Price:
6.17
Seasonality Move:
24.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2006-11-07 10Q KZIA/Kazia Therapeutics Quarterly

Receive KZIA News And Ratings

See the #1 stock for the next 7 days that we like better than KZIA

KZIA Financial Statistics

Sales & Book Value

Annual Sales: $11.33M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.14
Price / Book: 0

Profitability

EPS (TTM): -0.36670
Net Income (TTM): $-10.34M
Gross Margin: $1.58M
Return on Equity: 0%
Return on Assets: 0%

Kazia Therapeutics Earnings Forecast

Key Kazia Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 12 years for KZIA is 100.00%.
  • The Selling, General & Administrative Expenses for KZIA have been equal to 46.24% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 25 years have been positive in 13 years.

Kazia Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KZIA
CUSIP: 48669G
Website: kaziatherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KZIA Technical Analysis vs Fundamental Analysis

Buy
75
Kazia Therapeutics (KZIA) is a Buy

Is Kazia Therapeutics a Buy or a Sell?